This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Atherosclerotic cardiovasculardisease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 24,25 Among statin-treated patients with hsCRP greater than 2 mg/L, risks for cardiovascular death were high regardless of LDL-C level.21 4 In the U.S.
Objective We aimed to summarize the association between gestational diabetes mellitus (GDM) and its intergenerational cardiovasculardiseases (CVDs) impacts in both mothers and offspring post-delivery in existing literature.
Background and aims In the non-metropolitan region of Brandenburg (Germany), which is characterized by high rates of cardiovasculardiseases and underserved medical care, there is a lack of awareness regarding lipoprotein(a) [Lp(a)] as a risk factor. 3.95, p = 0.003). 3.95, p = 0.003). vs. 45.8%; 17.6% vs. 13.9%, p = 0.001).
Methods This narrative review examines the contemporary literature assessing intermediate- and long-term event rates in patients with established CV disease treated with statins. Recurrent stroke occurs in up to 19% of patients seven years after a first cerebrovascular event.
Background and aims Epidemiology of atherosclerotic cardiovasculardisease might be different in patients with polygenic hypercholesterolemia plus high levels (≥30 mg/dl) of Lp(a) (H-Lpa) than in those with polygenic hypercholesterolemia alone (H-LDL).
Six multimorbidity patterns were identified, including 4 specific patterns: (1) pattern 1, cerebrovascular cluster (histories of cerebrovasculardisease and hypertension); (2) pattern 2, traditional cardiovasculardisease risk factors cluster (histories of hyperlipidemia, obesity, anddiabetes, and family history of cardiovasculardisease and smoking); (..)
According to WHO , cardiovasculardiseases are the leading cause of death worldwide – it is estimated that they are the cause of 17.9 Cardiovasculardiseases are a group of diseases of the heart and blood vessels. They include coronaryarterydisease, cerebrovasculardisease, and rheumatic heart disease.
They increase the risk of hypertension, coronaryarterydisease, coronary vasospasm, arrhythmias, cardiomyopathy, cardiac arrest, and stroke. decline in overall CVD mortality rates (Table). Stratifying by drug type, methamphetamine-involved CVD death rates increased by 14.9% AAPC, compared to a 3.1%
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content